IgG4-related diseases of the digestive tract

JM Löhr, M Vujasinovic, J Rosendahl… - Nature Reviews …, 2022 - nature.com
IgG4-related conditions affecting the digestive tract are part of a multi-organ fibro-
inflammatory disorder termed IgG4-related disease (IgG4-RD), with autoimmune pancreatitis …

Recent advances in autoimmune pancreatitis

PA Hart, Y Zen, ST Chari - Gastroenterology, 2015 - Elsevier
Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis that is characterized clinically
by frequent presentation with obstructive jaundice, histologically by a dense …

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

MH Chapman, D Thorburn, GM Hirschfield… - Gut, 2019 - gut.bmj.com
These guidelines on the management of primary sclerosing cholangitis (PSC) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …

European Guideline on IgG4-related digestive disease–UEG and SGF evidence-based recommendations

JM Löhr, U Beuers, M Vujasinovic… - United European …, 2020 - journals.sagepub.com
The overall objective of these guidelines is to provide evidence-based recommendations for
the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in …

International consensus for the treatment of autoimmune pancreatitis

K Okazaki, ST Chari, L Frulloni, MM Lerch, T Kamisawa… - Pancreatology, 2017 - Elsevier
Abstract Background and aims The International Consensus Diagnostic Criteria (ICDC) for
AIP has proposed two distinctive type of AIP, type 1 and type 2, and enabled us first to …

Clinical practice guidelines for IgG4‐related sclerosing cholangitis

T Kamisawa, T Nakazawa, S Tazuma… - Journal of Hepato …, 2019 - Wiley Online Library
IgG4‐related sclerosing cholangitis (IgG4‐SC) is a distinct type of cholangitis frequently
associated with autoimmune pancreatitis and currently recognized as a biliary manifestation …

Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis

A Masamune, I Nishimori, K Kikuta, I Tsuji, N Mizuno… - Gut, 2017 - gut.bmj.com
Objective Corticosteroid has been established as the standard therapy for autoimmune
pancreatitis (AIP), but the requirement for maintenance corticosteroid therapy is …

S3-leitlinie pankreatitis–leitlinie der deutschen gesellschaft für gastroenterologie, verdauungs-und stoffwechselkrankheiten (DGVS)–september 2021–AWMF …

G Beyer, A Hoffmeister, P Michl… - Zeitschrift für …, 2022 - thieme-connect.com
Diese Leitlinie umfasst erstmals die akute wie auch die chronische Pankreatitis, um so
Übergänge der beiden ehemals getrennt wahrgenommenen Krankheitsbilder gemäß einem …

Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort

EL Culver, R Sadler, D Simpson, T Cargill… - Official journal of the …, 2016 - journals.lww.com
OBJECTIVES: Elevated serum immunoglobulin G4 (IgG4) levels have been associated with
autoimmune pancreatitis and IgG4-related disease (IgG4-RD) for over a decade. However …

An International multispecialty validation study of the IgG4‐related disease responder index

ZS Wallace, A Khosroshahi… - Arthritis care & …, 2018 - Wiley Online Library
Objective IgG4‐related disease (IgG4‐RD) can cause fibroinflammatory lesions in nearly
any organ, leading to organ dysfunction and failure. The IgG4‐RD Responder Index (RI) …